$SGMO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SANGAMO THERAPEUTICS, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SANGAMO THERAPEUTICS, INC. Get notifications about new insider transactions in SANGAMO THERAPEUTICS, INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 16 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 09 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Buy | M | 4.54 | 10,000 | 45,400 | 224,660 | 214.7 K to 224.7 K (+4.66 %) |
| Dec 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 5.70 | 7,000 | 39,900 | 58,172 | |
| Dec 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 5.35 | 5,000 | 26,750 | 50,000 | |
| Dec 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 3.45 | 3,000 | 10,350 | 34,500 | |
| Dec 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Sell | S | 11.68 | 15,000 | 175,191 | 109,347 | 124.3 K to 109.3 K (-12.06 %) |
| Dec 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 5.70 | 7,000 | 39,900 | 124,347 | 117.3 K to 124.3 K (+5.97 %) |
| Dec 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 5.35 | 5,000 | 26,750 | 117,347 | 112.3 K to 117.3 K (+4.45 %) |
| Dec 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 3.45 | 3,000 | 10,350 | 112,347 | 109.3 K to 112.3 K (+2.74 %) |
| Nov 19 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | M | 4.11 | 25,000 | 102,750 | 25,000 | |
| Nov 19 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 11.23 | 25,000 | 280,843 | 295,000 | 320 K to 295 K (-7.81 %) |
| Nov 19 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Buy | M | 4.11 | 25,000 | 102,750 | 320,000 | 295 K to 320 K (+8.47 %) |
| Nov 13 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 11.37 | 2,000 | 22,748 | 213,353 | 215.4 K to 213.4 K (-0.93 %) |
| Nov 13 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Option Exercise | M | 4.10 | 10,000 | 41,000 | 0 | |
| Nov 13 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 12.00 | 10,000 | 120,007 | 214,660 | 224.7 K to 214.7 K (-4.45 %) |
| Nov 13 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Buy | M | 4.10 | 10,000 | 41,000 | 224,660 | 214.7 K to 224.7 K (+4.66 %) |
| Nov 07 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 6.82 | 8,202 | 55,938 | 41,798 | |
| Nov 07 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 4.11 | 6,798 | 27,940 | 0 | |
| Nov 07 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 11.35 | 15,000 | 170,258 | 97,856 | 112.9 K to 97.9 K (-13.29 %) |
| Nov 07 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 6.82 | 8,202 | 55,938 | 112,856 | 104.7 K to 112.9 K (+7.84 %) |
| Nov 07 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 4.11 | 6,798 | 27,940 | 104,654 | 97.9 K to 104.7 K (+6.95 %) |
| Nov 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 5.70 | 5,000 | 28,500 | 65,172 | |
| Nov 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 5.35 | 5,000 | 26,750 | 55,000 | |
| Nov 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 3.45 | 3,000 | 10,350 | 37,500 | |
| Nov 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 6.82 | 2,000 | 13,640 | 0 | |
| Nov 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Sell | S | 11.91 | 15,000 | 178,704 | 109,347 | 124.3 K to 109.3 K (-12.06 %) |
| Nov 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 5.70 | 5,000 | 28,500 | 124,347 | 119.3 K to 124.3 K (+4.19 %) |
| Nov 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 5.35 | 5,000 | 26,750 | 119,347 | 114.3 K to 119.3 K (+4.37 %) |
| Nov 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 3.45 | 3,000 | 10,350 | 114,347 | 111.3 K to 114.3 K (+2.69 %) |
| Nov 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 6.82 | 2,000 | 13,640 | 111,347 | 109.3 K to 111.3 K (+1.83 %) |
| Oct 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Option Exercise | M | 7.28 | 10,000 | 72,800 | 0 | |
| Oct 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 12.02 | 10,000 | 120,153 | 214,660 | 224.7 K to 214.7 K (-4.45 %) |
| Oct 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Buy | M | 7.28 | 10,000 | 72,800 | 224,660 | 214.7 K to 224.7 K (+4.66 %) |
| Oct 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Gift | G | 0.00 | 2,500 | 0 | 214,660 | 217.2 K to 214.7 K (-1.15 %) |
| Oct 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | M | 4.11 | 25,000 | 102,750 | 50,000 | |
| Oct 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 10.49 | 25,000 | 262,365 | 295,000 | 320 K to 295 K (-7.81 %) |
| Oct 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Buy | M | 4.11 | 25,000 | 102,750 | 320,000 | 295 K to 320 K (+8.47 %) |
| Oct 14 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 10.10 | 2,000 | 20,200 | 214,347 | 216.3 K to 214.3 K (-0.92 %) |
| Oct 08 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 4.11 | 15,000 | 61,650 | 6,798 | |
| Oct 08 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 10.72 | 15,000 | 160,865 | 96,579 | 111.6 K to 96.6 K (-13.44 %) |
| Oct 08 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 4.11 | 15,000 | 61,650 | 111,579 | 96.6 K to 111.6 K (+15.53 %) |
| Oct 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 5.35 | 5,000 | 26,750 | 60,000 | |
| Oct 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 3.45 | 3,000 | 10,350 | 40,500 | |
| Oct 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 6.82 | 7,000 | 47,740 | 2,000 | |
| Oct 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Sell | S | 10.80 | 15,000 | 162,029 | 109,347 | 124.3 K to 109.3 K (-12.06 %) |
| Oct 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 5.35 | 5,000 | 26,750 | 124,347 | 119.3 K to 124.3 K (+4.19 %) |
| Oct 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 3.45 | 3,000 | 10,350 | 119,347 | 116.3 K to 119.3 K (+2.58 %) |
| Oct 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 6.82 | 7,000 | 47,740 | 116,347 | 109.3 K to 116.3 K (+6.40 %) |
| Sep 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | M | 4.11 | 25,000 | 102,750 | 75,000 | |
| Sep 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 12.14 | 25,000 | 303,383 | 295,000 | 320 K to 295 K (-7.81 %) |
| Sep 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Buy | M | 4.11 | 25,000 | 102,750 | 320,000 | 295 K to 320 K (+8.47 %) |
| Sep 12 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 12.31 | 2,000 | 24,620 | 216,347 | 218.3 K to 216.3 K (-0.92 %) |
| Sep 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 4.11 | 15,000 | 61,650 | 21,798 | |
| Sep 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 12.20 | 15,000 | 183,072 | 96,579 | 111.6 K to 96.6 K (-13.44 %) |
| Sep 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 4.11 | 15,000 | 61,650 | 111,579 | 96.6 K to 111.6 K (+15.53 %) |
| Sep 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Option Exercise | M | 7.73 | 10,000 | 77,300 | 0 | |
| Sep 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Gift | G | 0.00 | 1,000 | 0 | 217,160 | 218.2 K to 217.2 K (-0.46 %) |
| Sep 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 12.81 | 10,000 | 128,082 | 218,160 | 228.2 K to 218.2 K (-4.38 %) |
| Sep 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Buy | M | 7.73 | 10,000 | 77,300 | 228,160 | 218.2 K to 228.2 K (+4.58 %) |
| Sep 04 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 5.35 | 5,000 | 26,750 | 65,000 | |
| Sep 04 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 3.45 | 3,000 | 10,350 | 43,500 | |
| Sep 04 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 6.82 | 7,000 | 47,740 | 9,000 | |
| Sep 04 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Sell | S | 13.45 | 15,000 | 201,798 | 109,347 | 124.3 K to 109.3 K (-12.06 %) |
| Sep 04 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 5.35 | 5,000 | 26,750 | 124,347 | 119.3 K to 124.3 K (+4.19 %) |
| Sep 04 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 3.45 | 3,000 | 10,350 | 119,347 | 116.3 K to 119.3 K (+2.58 %) |
| Sep 04 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 6.82 | 7,000 | 47,740 | 116,347 | 109.3 K to 116.3 K (+6.40 %) |
| Aug 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | M | 4.11 | 25,000 | 102,750 | 100,000 | |
| Aug 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 13.95 | 25,000 | 348,798 | 295,000 | 320 K to 295 K (-7.81 %) |
| Aug 15 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Buy | M | 4.11 | 25,000 | 102,750 | 320,000 | 295 K to 320 K (+8.47 %) |
| Aug 12 2014 | SGMO | SANGAMO BIOSCIENCE ... | Ramasastry Saira | Director | Option Exercise | M | 5.03 | 10,000 | 50,300 | 24,450 | |
| Aug 12 2014 | SGMO | SANGAMO BIOSCIENCE ... | Ramasastry Saira | Director | Sell | S | 14.00 | 10,000 | 140,000 | 0 | 10 K to 0 (-100.00 %) |
| Aug 12 2014 | SGMO | SANGAMO BIOSCIENCE ... | Ramasastry Saira | Director | Buy | M | 5.03 | 10,000 | 50,300 | 10,000 | 0 to 10 K |
| Aug 12 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 7.28 | 8,000 | 58,240 | 0 | |
| Aug 12 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 14.14 | 2,000 | 28,287 | 218,347 | 220.3 K to 218.3 K (-0.91 %) |
| Aug 12 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 14.17 | 8,000 | 113,390 | 220,347 | 228.3 K to 220.3 K (-3.50 %) |
| Aug 12 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 7.28 | 8,000 | 58,240 | 228,347 | 220.3 K to 228.3 K (+3.63 %) |
| Aug 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 4.11 | 13,202 | 54,260 | 36,798 | |
| Aug 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 12.98 | 1,798 | 23,339 | 96,579 | 98.4 K to 96.6 K (-1.83 %) |
| Aug 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 12.99 | 13,202 | 171,507 | 98,377 | 111.6 K to 98.4 K (-11.83 %) |
| Aug 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 4.11 | 13,202 | 54,260 | 111,579 | 98.4 K to 111.6 K (+13.42 %) |
| Aug 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Option Exercise | M | 4.00 | 10,000 | 40,000 | 0 | |
| Aug 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 12.56 | 10,000 | 125,578 | 218,160 | 228.2 K to 218.2 K (-4.38 %) |
| Aug 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Buy | M | 4.00 | 10,000 | 40,000 | 228,160 | 218.2 K to 228.2 K (+4.58 %) |
| Aug 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 5.35 | 5,000 | 26,750 | 70,000 | |
| Aug 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 3.45 | 3,000 | 10,350 | 46,500 | |
| Aug 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 6.82 | 7,000 | 47,740 | 16,000 | |
| Aug 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Sell | S | 12.54 | 15,000 | 188,150 | 109,347 | 124.3 K to 109.3 K (-12.06 %) |
| Aug 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 5.35 | 5,000 | 26,750 | 124,347 | 119.3 K to 124.3 K (+4.19 %) |
| Aug 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 3.45 | 3,000 | 10,350 | 119,347 | 116.3 K to 119.3 K (+2.58 %) |
| Aug 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 6.82 | 7,000 | 47,740 | 116,347 | 109.3 K to 116.3 K (+6.40 %) |
| Jul 18 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | M | 4.11 | 25,000 | 102,750 | 125,000 | |
| Jul 18 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 12.16 | 25,000 | 303,940 | 295,000 | 320 K to 295 K (-7.81 %) |
| Jul 18 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Buy | M | 4.11 | 25,000 | 102,750 | 320,000 | 295 K to 320 K (+8.47 %) |
| Jul 11 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 7.28 | 2,000 | 14,560 | 8,000 | |
| Jul 11 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 7.73 | 11,000 | 85,030 | 0 | |
| Jul 11 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 13.19 | 2,000 | 26,375 | 220,347 | 222.3 K to 220.3 K (-0.90 %) |
| Jul 11 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 13.27 | 13,000 | 172,527 | 222,347 | 235.3 K to 222.3 K (-5.52 %) |
| Jul 11 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 7.28 | 2,000 | 14,560 | 235,347 | 233.3 K to 235.3 K (+0.86 %) |
| Jul 11 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 7.73 | 11,000 | 85,030 | 233,347 | 222.3 K to 233.3 K (+4.95 %) |
| Jul 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 5.35 | 5,000 | 26,750 | 75,000 | |
| Jul 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 3.45 | 3,000 | 10,350 | 49,500 | |
| Jul 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 6.82 | 7,000 | 47,740 | 23,000 | |
| Jul 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Sell | S | 15.66 | 15,000 | 234,866 | 109,347 | 124.3 K to 109.3 K (-12.06 %) |
| Jul 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 5.35 | 5,000 | 26,750 | 124,347 | 119.3 K to 124.3 K (+4.19 %) |
| Jul 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 3.45 | 3,000 | 10,350 | 119,347 | 116.3 K to 119.3 K (+2.58 %) |
| Jul 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 6.82 | 7,000 | 47,740 | 116,347 | 109.3 K to 116.3 K (+6.40 %) |
| Jun 25 2014 | SGMO | SANGAMO BIOSCIENCE ... | Ramasastry Saira | Director | Option Exercise | M | 5.03 | 5,550 | 27,917 | 34,450 | |
| Jun 25 2014 | SGMO | SANGAMO BIOSCIENCE ... | Ramasastry Saira | Director | Sell | S | 15.53 | 5,550 | 86,217 | 0 | 5.6 K to 0 (-100.00 %) |
| Jun 25 2014 | SGMO | SANGAMO BIOSCIENCE ... | Ramasastry Saira | Director | Buy | M | 5.03 | 5,550 | 27,917 | 5,550 | 0 to 5.6 K |
| Jun 19 2014 | SGMO | SANGAMO BIOSCIENCE ... | PARKER H STEWART | Director | Option Exercise | A | 16.73 | 50,000 | 836,500 | 50,000 | |
| Jun 18 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 16.41 | 25,000 | 410,138 | 1,516,054 | 1.5 M to 1.5 M (-1.62 %) |
| Jun 11 2014 | SGMO | SANGAMO BIOSCIENCE ... | Mento Steven J | Director | Option Exercise | M | 7.28 | 5,834 | 42,472 | 0 | |
| Jun 11 2014 | SGMO | SANGAMO BIOSCIENCE ... | Mento Steven J | Director | Sell | S | 15.00 | 4,328 | 64,920 | 25,069 | 29.4 K to 25.1 K (-14.72 %) |
| Jun 11 2014 | SGMO | SANGAMO BIOSCIENCE ... | Mento Steven J | Director | Buy | M | 7.28 | 5,834 | 42,472 | 29,397 | 23.6 K to 29.4 K (+24.76 %) |
| Jun 11 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 7.73 | 13,000 | 100,490 | 11,000 | |
| Jun 11 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 15.63 | 2,000 | 31,254 | 222,347 | 224.3 K to 222.3 K (-0.89 %) |
| Jun 11 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 15.62 | 13,000 | 203,074 | 224,347 | 237.3 K to 224.3 K (-5.48 %) |
| Jun 11 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 7.73 | 13,000 | 100,490 | 237,347 | 224.3 K to 237.3 K (+5.79 %) |
| Jun 04 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 5.35 | 5,000 | 26,750 | 80,000 | |
| Jun 04 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 3.45 | 3,000 | 10,350 | 52,500 | |
| Jun 04 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 6.82 | 7,000 | 47,740 | 30,000 | |
| Jun 04 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Sell | S | 12.85 | 15,000 | 192,723 | 109,347 | 124.3 K to 109.3 K (-12.06 %) |
| Jun 04 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 5.35 | 5,000 | 26,750 | 124,347 | 119.3 K to 124.3 K (+4.19 %) |
| Jun 04 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 3.45 | 3,000 | 10,350 | 119,347 | 116.3 K to 119.3 K (+2.58 %) |
| Jun 04 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 6.82 | 7,000 | 47,740 | 116,347 | 109.3 K to 116.3 K (+6.40 %) |
| May 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 2,000 | 10,380 | 0 | |
| May 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 13,000 | 44,850 | 114,000 | |
| May 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 13.57 | 2,000 | 27,134 | 98,377 | 100.4 K to 98.4 K (-1.99 %) |
| May 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 2,000 | 10,380 | 100,377 | 98.4 K to 100.4 K (+2.03 %) |
| May 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 13.57 | 13,000 | 176,397 | 98,377 | 111.4 K to 98.4 K (-11.67 %) |
| May 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 13,000 | 44,850 | 111,377 | 98.4 K to 111.4 K (+13.21 %) |
| May 16 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 13.14 | 25,000 | 328,543 | 1,541,054 | 1.6 M to 1.5 M (-1.60 %) |
| May 14 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 7.73 | 13,000 | 100,490 | 24,000 | |
| May 14 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 12.85 | 2,000 | 25,696 | 224,347 | 226.3 K to 224.3 K (-0.88 %) |
| May 14 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 12.85 | 13,000 | 167,059 | 226,347 | 239.3 K to 226.3 K (-5.43 %) |
| May 14 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 7.73 | 13,000 | 100,490 | 239,347 | 226.3 K to 239.3 K (+5.74 %) |
| Apr 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 2,000 | 10,380 | 2,000 | |
| Apr 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 13,000 | 44,850 | 127,000 | |
| Apr 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | S | 13.63 | 2,000 | 27,255 | 97,015 | 95 K to 97 K (+2.10 %) |
| Apr 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 2,000 | 10,380 | 99,015 | 97 K to 99 K (+2.06 %) |
| Apr 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | S | 13.64 | 13,000 | 177,277 | 97,015 | 84 K to 97 K (+15.47 %) |
| Apr 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 13,000 | 44,850 | 110,015 | 97 K to 110 K (+13.40 %) |
| May 02 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 5.35 | 5,000 | 26,750 | 85,000 | |
| May 02 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 3.45 | 3,000 | 10,350 | 55,500 | |
| May 02 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 6.82 | 7,000 | 47,740 | 37,000 | |
| May 02 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Sell | S | 13.68 | 15,000 | 205,179 | 109,347 | 124.3 K to 109.3 K (-12.06 %) |
| May 02 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 5.35 | 5,000 | 26,750 | 124,347 | 119.3 K to 124.3 K (+4.19 %) |
| May 02 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 3.45 | 3,000 | 10,350 | 119,347 | 116.3 K to 119.3 K (+2.58 %) |
| May 02 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 6.82 | 7,000 | 47,740 | 116,347 | 109.3 K to 116.3 K (+6.40 %) |
| Apr 23 2014 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Option Exercise | A | 14.20 | 10,000 | 142,000 | 10,000 | |
| Apr 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Option Exercise | M | 5.66 | 10,000 | 56,600 | 0 |